Back to Search Start Over

Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy.

Authors :
Galitzia A
Murru R
Caocci G
Barabino L
Azzena A
Licheri VM
Greco M
La Nasa G
Source :
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2023 Apr; Vol. 27 (8), pp. 3514-3518.
Publication Year :
2023

Abstract

Background: Persistent polyclonal B-cell lymphocytosis is a rare nonmalignant disorder characterized by mild persistent lymphocyte proliferation with possible evolution to aggressive lymphoma. Its biology is not well known, but it is characterized by a specific immunophenotype with rearrangement of the BCL-2/IGH gene, whereas amplification of the BCL-6 gene has rarely been reported. Given the paucity of reports, it has been hypothesized that this disorder is associated with poor pregnancy outcomes.<br />Case Report: To our knowledge, only two successful pregnancies have been described in women with this condition. We report the third successful pregnancy in a patient with PPBL and the first with amplification of the BCL-6 gene.<br />Conclusions: PPBL is still a poorly understood clinical condition with insufficient data to demonstrate an adverse effect on pregnancy. The role of BCL-6 dysregulation in the pathogenesis of PPBL and its prognostic significance are still unknown. Evolution into aggressive clonal lymphoproliferative disorders is possible and prolonged hematologic follow-up is warranted in patients with this rare clinical disorder.

Details

Language :
English
ISSN :
2284-0729
Volume :
27
Issue :
8
Database :
MEDLINE
Journal :
European review for medical and pharmacological sciences
Publication Type :
Academic Journal
Accession number :
37140301
Full Text :
https://doi.org/10.26355/eurrev_202304_32124